Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Beginning Cash Balance: 2020-2024

Historic Beginning Cash Balance for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $4.6 million.

  • Cardiol Therapeutics' Beginning Cash Balance fell 197.27% to -$11.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$11.3 million, marking a year-over-year decrease of 197.27%. This contributed to the annual value of $4.6 million for FY2024, which is 75.69% down from last year.
  • Cardiol Therapeutics' Beginning Cash Balance amounted to $4.6 million in FY2024, which was down 75.69% from $18.8 million recorded in FY2023.
  • In the past 5 years, Cardiol Therapeutics' Beginning Cash Balance registered a high of $21.0 million during FY2022, and its lowest value of -$5.3 million during FY2020.
  • Over the past 3 years, Cardiol Therapeutics' median Beginning Cash Balance value was $18.8 million (recorded in 2023), while the average stood at $14.8 million.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first soared by 310.25% in 2021, then slumped by 75.69% in 2024.
  • Over the past 5 years, Cardiol Therapeutics' Beginning Cash Balance (Yearly) stood at -$5.3 million in 2020, then spiked by 310.25% to $11.2 million in 2021, then skyrocketed by 88.11% to $21.0 million in 2022, then decreased by 10.86% to $18.8 million in 2023, then slumped by 75.69% to $4.6 million in 2024.